Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs Genelux Corporation (GNLX)

Foghorn Therapeutics Inc. and Genelux Corporation are both Biotechnology companies. Foghorn Therapeutics Inc. and Genelux Corporation are of similar size ($112.2M and $112.2M). Genelux Corporation has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Foghorn Therapeutics Inc. leads on 7 and Genelux Corporation on 6.

Valuation

Metric FHTX GNLX Biotechnology median
P/E n/m n/m 8.50
P/S 3.56 9.67 9.71
P/B n/m 6.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.24 n/m 0.64
EV/Sales (0.46) 8.77 9.21
Earnings yield (52.97%) (35.54%) (33.15%)
Free cash flow yield (64.53%) (26.36%) (25.50%)

Profitability

Metric FHTX GNLX Biotechnology median
Gross margin 100.00% (3.42%) 65.16%
Operating margin (198.04%) 0.00% 0.00%
Net margin (175.78%) 0.00% 0.00%
Free cash flow margin (229.49%) 0.00% 0.00%
Return on equity 81.90% (177.93%) (56.36%)
Return on assets (30.06%) (121.80%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FHTX GNLX Biotechnology median
Revenue growth (TTM) 51.98% — 6.02%
EPS growth (last fiscal year) 25.32% 9.47% 30.26%
Revenue growth, 5-year CAGR 135.14% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX GNLX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 2.39 4.72
Net debt to EBITDA 1.88 0.44 0.96

Dividend

Metric FHTX GNLX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FHTX GNLX Biotechnology median
Market cap 112.24m 112.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack